Olivia Munn’s Revelation: Breast Cancer Risk Assessment Tool Sparks Diagnosis – Expert Insights Unveiled!
On Wednesday, actress Olivia Munn disclosed her breast cancer diagnosis from the previous year, attributing the detection to a lesser-known risk assessment score. Despite having normal mammogram results and negative genetic testing for cancer in February 2023, Munn’s physician computed her breast cancer risk assessment score. This evaluation, considering factors such as age and family history, revealed a lifetime risk of 37%, prompting further screenings including MRI, ultrasound, and biopsy, which confirmed Luminal B cancer in both breasts. Subsequently, Munn underwent a double mastectomy within 30 days of the biopsy.
Munn emphasized that had her doctor not initiated a risk assessment for breast cancer, the disease would have remained undetected until her next scheduled mammogram. “Her decision ultimately saved my life,” she stated, urging other women to familiarize themselves with their risk scores.
Dr. Elisa Port, chief of breast surgery at Mt. Sinai Health System in New York, emphasized the availability of various risk models, such as the Gail Model and Tyrer-Cuzick risk model, which serve as surveys to gauge an individual’s risk level. “You can access these tools online,” Port advised on “CBS Mornings,” noting that they involve a series of questions.
The inquiries cover details such as:
- Present age
- Height and weight
- Family medical history
- Onset age of menstruation
- Maternity history
- Previous breast biopsy, including findings
Dr. Elizabeth Comen, a breast oncologist at Memorial Sloan Kettering Cancer Center, explained to CBS News, “If your score surpasses 20% lifetime risk of breast cancer, you might qualify for incorporating MRIs into your screening regimen, alongside potentially mammograms and ultrasounds.”
Port highlights that while reproductive factors have a limited impact on overall risk compared to other factors, family history remains a significant determinant. “The risk assessment tool provides a quantifiable number, but it’s crucial for most women to already recognize if they have a family history of breast cancer, indicating a heightened risk,” she emphasized.
According to Port, the average lifetime risk for most women stands at approximately 10% to 12%. As per recommended guidelines, mammograms should commence at age 40 for the general population. However, for individuals with elevated risk, healthcare providers may advise an earlier initiation.
“On the opposite end of the spectrum,” Port explained, “are women with genetic predisposition, facing a risk of about 60% to 80%, which represents the highest level of risk.” However, she emphasizes that all individuals are susceptible, highlighting that 85% to 90% of breast cancer cases occur in women without a family history.
“Many women assume they’re not at risk and overlook general screening,” Port observed. “Yet, even for the average woman without additional risk factors, the lifetime risk stands at 10% to 12%. This underscores the importance of undergoing appropriate screening tests.”
The key message conveyed by Munn’s narrative is clear, according to Port: Understand your risk.
“Whether it’s conducting your own research online or consulting a physician who can assess your risk through algorithms, these actions provide valuable insights into how to proactively manage your health,” she emphasized.
